Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH‐HD2002 trial

ConclusionOnly strongly enhanced residual FDG uptake in early response PET (vDS 5 or qPET ≥ 2, respectively) seems to be markedly prognostic in PHL when treatment according to the GPOH‐HD‐2002 protocol is given.

https://onlinelibrary.wiley.com/doi/abs/10.1002/pbc.27539?af=R

Source: Pediatric Blood and Cancer - November 14, 2018 Category: Cancer & Oncology Authors: L. Kurch, D. Hasenclever, R. Kluge, T. Georgi, L. Tchavdarova, M. Golombeck, O. Sabri, A. Eggert, W. Brenner, K.W. Sykora, F.M. Bengel, C. Rossig, D. K örholz, M. Schäfers, T. Feuchtinger, P. Bartenstein, R.A. Ammann, T. Krause, C. Urb Tags: RESEARCH ARTICLE Source Type: research